The government will soon announce the first 10 medications that will be subject to price negotiations with Medicare under a new law. Drugmakers are fighting the measure in court.
Drugmakers Throw ‘Kitchen Sink’ to Halt Medicare Price Negotiations
Written by
in
Centers for Medicare and Medicaid Services, Drugs (Pharmaceuticals), Health and Human Services Department, Health Insurance and Managed Care, Inflation Reduction Act of 2022, Johnson & Johnson, Law and Legislation, Medicare, Merck & Company Inc, Pharmaceutical Research and Manufacturers of America, Prices (Fares, Fees and Rates), Suits and Litigation (Civil), United States Chamber of Commerce, United States Politics and Government